Bliss GVS Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has submitted a certificate to the stock exchange under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing typically submitted by companies to confirm adherence to rules related to dematerialisation of shares and maintenance of electronic records with depositories such as NSDL and CDSL. No specific financial numbers or material business update is included in the headline.
This appears to be a standard regulatory compliance disclosure with no direct impact on the company's financials, operations, or share price. Investors should treat this as routine housekeeping rather than a material event.